Alexander W. Charney: Leveraging genomics to advance the treatment of mental illness

Dr. Alexander Charney is a physician-scientist and academic leader at the Icahn School of Medicine at Mount Sinai, where he holds professorships in Artificial Intelligence, Psychiatry, Genetics, and Genomic Sciences. As Vice Chair of the Windreich Department of Artificial Intelligence and Human Health and Director of the Charles Bronfman Institute for Personalized Medicine, he is advancing the frontiers of precision medicine and digital health. Dr. Charney leads high-impact research programs such as the Mount Sinai Million Health Discoveries Program and the Living Brain Project, with a focus on schizophrenia, personalized experimental therapeutics, and AI-driven discovery. He has secured major NIH funding and helped drive landmark findings in psychiatric genetics through the Psychiatric Genomics Consortium. A transformative institutional leader, Dr. Charney has launched pioneering clinical trials, forged strategic partnerships, and helped shape Mount Sinai's research-track psychiatry residency. His work bridges the gap between science and clinical care, setting new standards in translational neuroscience and personalized medicine. In this exclusive Genomic Press Interview, Dr. Charney shares with our readers insights into his life and career.